BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 27038440)

  • 1. A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.
    Snape SD; Wigger-Alberti W; Goehring UM
    Br J Dermatol; 2016 Sep; 175(3):479-86. PubMed ID: 27038440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.
    Papp KA; Gooderham M; Droege M; Merritt C; Osborne DW; Berk DR; Thurston AW; Smith VH; Welgus H
    J Drugs Dermatol; 2020 Aug; 19(8):734-740. PubMed ID: 32845114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of Roflumilast Cream for Chronic Plaque Psoriasis.
    Lebwohl MG; Papp KA; Stein Gold L; Gooderham MJ; Kircik LH; Draelos ZD; Kempers SE; Zirwas M; Smith K; Osborne DW; Trotman ML; Navale L; Merritt C; Berk DR; Welgus H;
    N Engl J Med; 2020 Jul; 383(3):229-239. PubMed ID: 32668113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
    Lebwohl MG; Kircik LH; Moore AY; Stein Gold L; Draelos ZD; Gooderham MJ; Papp KA; Bagel J; Bhatia N; Del Rosso JQ; Ferris LK; Green LJ; Hebert AA; Jones T; Kempers SE; Pariser DM; Yamauchi PS; Zirwas M; Albrecht L; Devani AR; Lomaga M; Feng A; Snyder S; Burnett P; Higham RC; Berk DR
    JAMA; 2022 Sep; 328(11):1073-1084. PubMed ID: 36125472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis.
    Smith B; Collier MR; Wu JJ
    JAMA; 2023 Feb; 329(7):594-595. PubMed ID: 36809326
    [No Abstract]   [Full Text] [Related]  

  • 7. Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis-Reply.
    Lebwohl MG; Hebert AA; Gooderham MJ
    JAMA; 2023 Feb; 329(7):595. PubMed ID: 36809324
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
    Naldi L; Yawalkar N; Kaszuba A; Ortonne JP; Morelli P; Rovati S; Mautone G
    Am J Clin Dermatol; 2011 Jun; 12(3):191-201. PubMed ID: 21284407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis.
    Nicolas SE; Bear MD; Kanaan AO; Coman OA; Dima L
    Am J Ther; 2023 Nov-Dec 01; 30(6):e535-e542. PubMed ID: 37921681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies.
    Thurston AW; Osborne DW; Snyder S; Higham RC; Burnett P; Berk DR
    Am J Clin Dermatol; 2023 Mar; 24(2):315-324. PubMed ID: 36422852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis - results from a randomized controlled trial (PSORRO).
    Gyldenløve M; Sørensen JA; Fage S; Meteran H; Skov L; Zachariae C; Knop FK; Nielsen ML; Egeberg A
    J Am Acad Dermatol; 2024 Jul; 91(1):64-71. PubMed ID: 38431099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Roflumilast for Plaque Psoriasis.
    O'Toole A; Gooderham M
    Skin Therapy Lett; 2023 Sep; 28(5):1-4. PubMed ID: 37734074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
    Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy.
    Kragballe K; Barnes L; Hamberg KJ; Hutchinson P; Murphy F; Møller S; Ruzicka T; Van De Kerkhof PC
    Br J Dermatol; 1998 Oct; 139(4):649-54. PubMed ID: 9892908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the antipsoriatic effect and tolerability of calcipotriol-containing products in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.
    Queille-Roussel C; Hoffmann V; Ganslandt C; Hansen KK
    Clin Drug Investig; 2012 Sep; 32(9):613-9. PubMed ID: 22845045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.
    Ports WC; Khan S; Lan S; Lamba M; Bolduc C; Bissonnette R; Papp K
    Br J Dermatol; 2013 Jul; 169(1):137-45. PubMed ID: 23387374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on topical therapies for psoriasis.
    Pender EK; Kirby B
    Curr Opin Rheumatol; 2024 Jul; 36(4):289-294. PubMed ID: 38651512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.